Recent Canadian Study Published In BMJ Medical Journal Suggests The Increased Risk Of Diabetes Seems To Be Highest In The First Four Months Of Statin Use
SUMMARY: In May 2014 the medical journal BMJ published this article, “Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases”, which further implicates higher doses of Lipitor as a possible cause of new-onset Type-2 diabetes in some adult women.
For some contextual information concerning this recent statins – diabetes medical journal article we refer to this June 9, 2014 Reuters news report, “Higher doses of statins linked to diabetes risk”:
The researchers considered rosuvastatin (brand name Crestor) prescribed at 10 milligrams or more per day, atorvastatin (Lipitor) at 20 mg or more and simvastatin (Zocor) at 40 mg or more to be higher-potency statins. All other dosages were considered lower potency.
We will continue to monitor this emerging drug-safety issue concerning association between new-onset diabetes mellitus (DM), or Type-2 diabetes, and higher doses of Lipitor as well as other statins.[Read this article in full at original source]